Results 131 to 140 of about 210,920 (352)

Adenosine A3 receptor antagonists as anti‐tumor treatment in human prostate cancer: an in vitro study

FEBS Open Bio, EarlyView.
The A3 adenosine receptors (A3ARs) are overexpressed in prostate cancer. AR 292 and AR 357, as A3AR antagonists, are capable of blocking proliferation, modulating the expression of drug transporter genes involved in chemoresistance, ferroptosis, and the hypoxia response, and inducing cell death.
Maria Beatrice Morelli, Andrea Spinaci, Cui Chang, Rosaria Volpini, Catia Lambertucci, Matteo Landriscina, Vincenza Conteduca, Consuelo Amantini, Cristina Aguzzi, Laura Zeppa, Martina Giangrossi, Laura Soverchia, Matteo Santoni, Massimo Nabissi, Giorgio Santoni, Carlo Polidori   +15 more
wiley   +1 more source

Avaliação do uso de extrato de timo (timulina) em pacientes com neoplasia maligna submetidos ao tratamento cirúrgico

Revista do Colégio Brasileiro de Cirurgiões
OBJETIVO: Avaliar a ação da timulina em pacientes com neoplasia maligna, submetidos ao tratamento, com e sem quimioterapia e radioterapia complementar (QT/RT).
Célia Regina de Oliveira Garritano
doaj   +1 more source

Safe Handling of Antineoplastic Drugs in Oncology Nursing

Sağlık ve Hemşirelik Yönetimi Dergisi, 2014
Today the oncology nursing importance has been increased because of that cancer is one of the most important health problem in Turkey, as it is in the other countries throughout the world. By the way antineoplalastic drugs, which not only effect patients
Rujnan Tuna
doaj   +1 more source

Antineoplastic agents 32. The pseudoguaianolide helenalin [PDF]

, 1973
George R. Pettit, Gordon M. Cragg
openalex   +1 more source

VAIN: Attentional Multi-agent Predictive Modeling [PDF]

arXiv, 2017
Multi-agent predictive modeling is an essential step for understanding physical, social and team-play systems. Recently, Interaction Networks (INs) were proposed for the task of modeling multi-agent physical systems, INs scale with the number of interactions in the system (typically quadratic or higher order in the number of agents).
arxiv  

Downregulation of O‐GlcNAcylation enhances etoposide‐induced p53‐mediated apoptosis in HepG2 human liver cancer cells

FEBS Open Bio, EarlyView.
Etoposide, a topoisomerase II inhibitor, reduces O‐GlcNAcylation in HepG2 liver cancer cells. Further inhibition of O‐GlcNAc transferase by OSMI‐1 enhanced etoposide‐induced apoptosis, lowering the IC50 for viability and increasing the EC50 for cytotoxicity.
Jaehoon Lee, Gi‐Bang Koo, Jihye Park, Byung‐Cheol Han, Mijin Kwon, Seung‐Ho Lee   +5 more
wiley   +1 more source

Evaluation of the Impact of Implementing Electronic Prescription in an Oncology Referral Hospital in Recife, Brazil

Brazilian Journal of Oncology
Introduction The occurrence of errors in the prescription of antineoplastic oncological drugs constitutes a serious public health problem, directly affecting patient safety.
Diana Carla Gouveia Falcão, Ana Lara Vieira Soares, Hermes Castro de Araujo-Junior, José Kilderlan Nascimento de Souza-Filho, Natália Moura Farias de Medeiros, Paulo Victor Brasileiro Mota, Rodolfo Basílio Madeira-Neto, Tiago Costa Maia, Marcio Roberto Pinho Pereira, Maria Angelina Silva Medeiros   +9 more
doaj   +1 more source

Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents-updated MASCC/ESMO consensus recommendation. [PDF]

Support Care Cancer, 2023
Jordan K, Chan A, Gralla RJ, Jahn F, Rapoport B, Ruhlmann CH, Sayegh P, Hesketh PJ.   +7 more
europepmc   +1 more source

Probabilistic Agent Programs [PDF]

arXiv, 1999
Agents are small programs that autonomously take actions based on changes in their environment or ``state.'' Over the last few years, there have been an increasing number of efforts to build agents that can interact and/or collaborate with other agents.
arxiv  

Understanding and Overcoming Immunotherapy Resistance in Skin Cancer: Mechanisms and Strategies

Aging and Cancer, EarlyView.
This narrative review explores the mechanisms driving immunotherapy resistance in skin cancer, including tumor microenvironment factors, genetic mutations, and immune evasion strategies. It highlights potential strategies to overcome resistance, offering insights for improving therapeutic outcomes and guiding future research in personalized ...
Shreya Singh Beniwal, Abhimanyu Chiraparambil Radhakrishnan, Ayanchetty Haripraba, Saif Syed, Gajawada Pragna, Ayush Dwivedi, Akash Rawat, Daniela Castro Calderón, Martin Cevallos‐Cueva   +8 more
wiley   +1 more source